Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
March 25 2020 - 3:02PM
Edgar (US Regulatory)
Filed by AcelRx Pharmaceuticals, Inc.
(Commission File No. 001-35068)
pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
under the Securities Exchange Act of 1934
Subject Company: Tetraphase Pharmaceutials, Inc.
(Commission File No. 001-35837
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From Apr 2024 to May 2024
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Tetraphase Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Tetraphase Pharmaceuticals Inc News Articles